Drug Combination Comprising A Glycolysis Inhibitor And A Tyrosine Kinase Inhibitor

Uri Nir; Sally Shpungin

Drug Combination Comprising A Glycolysis Inhibitor And A Tyrosine Kinase Inhibitor

Uri Nir (Inventor), Sally Shpungin (Inventor)

The Mina and Everard Goodman Faculty of Life Sciences

Bar-Ilan University

Research output: Patent

Abstract

A drug combination comprising at least one inhibitor of tyrosine kinase and at least one inhibitor of glycolysis. The drug combination may be used in the treatment of proliferative disorders, such as liver or colon cancer. The inhibitor of tyrosine kinase may be an inhibitor of at least one of the tyrosine kinases Fer and FerT.

Original language	English
Patent number	US20130072448A1
State	Published - 1 Mar 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@misc{cfb9687f5cc340c099c865cc0d6a91d7,

title = "Drug Combination Comprising A Glycolysis Inhibitor And A Tyrosine Kinase Inhibitor",

abstract = "A drug combination comprising at least one inhibitor of tyrosine kinase and at least one inhibitor of glycolysis. The drug combination may be used in the treatment of proliferative disorders, such as liver or colon cancer. The inhibitor of tyrosine kinase may be an inhibitor of at least one of the tyrosine kinases Fer and FerT.",

author = "Uri Nir and Sally Shpungin",

note = "US Patent App. 13/677,231; US20130072448A1",

year = "2013",

month = mar,

day = "1",

language = "الإنجليزيّة",

type = "Patent",

}

TY - PAT

T1 - Drug Combination Comprising A Glycolysis Inhibitor And A Tyrosine Kinase Inhibitor

AU - Nir, Uri

AU - Shpungin, Sally

N1 - US Patent App. 13/677,231

PY - 2013/3/1

Y1 - 2013/3/1

N2 - A drug combination comprising at least one inhibitor of tyrosine kinase and at least one inhibitor of glycolysis. The drug combination may be used in the treatment of proliferative disorders, such as liver or colon cancer. The inhibitor of tyrosine kinase may be an inhibitor of at least one of the tyrosine kinases Fer and FerT.

AB - A drug combination comprising at least one inhibitor of tyrosine kinase and at least one inhibitor of glycolysis. The drug combination may be used in the treatment of proliferative disorders, such as liver or colon cancer. The inhibitor of tyrosine kinase may be an inhibitor of at least one of the tyrosine kinases Fer and FerT.

UR - https://patents.google.com/patent/US20130072448A1/en

M3 - براءة الإختراع

M1 - US20130072448A1

ER -

Drug Combination Comprising A Glycolysis Inhibitor And A Tyrosine Kinase Inhibitor

Abstract

UN SDGs

Other files and links

Cite this